Long-Term Follow up of BMT CTN 0901, a Randomized Phase III Trial Comparing Myeloablative (MAC) to Reduced Intensity Conditioning (RIC) Prior to Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML) or Myelodysplasia (MDS) (MAvRIC Trial)

BMT CTN 0901 enrolled patients with MDS (N=54) or AML (N=218) (median age of 55 years) who had

Source: Biology of Blood and Marrow Transplantation - January 24, 2020 Category: Hematology Authors: Bart L. Scott Tags: 11 Source Type: research